Skip to Content

Vinorelbine Pregnancy and Breastfeeding Warnings

Vinorelbine is also known as: Navelbine

Vinorelbine Pregnancy Warnings

Vinorelbine has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryotoxicity and fetotoxicity. There are no controlled data in human pregnancy. Vinorelbine should only be given during pregnancy when there are no alternatives and benefit outweighs risk. It is recommended that women of childbearing age be advised to avoid becoming pregnant while receiving therapy with vinorelbine.

If vinorelbine is used during pregnancy, or if the patient becomes pregnant while receiving the drug, then it is recommended that the patient be made aware of the potential hazard to the fetus.

See references

Vinorelbine Breastfeeding Warnings

There are no data on the excretion of vinorelbine into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to vinorelbine in nursing infants, it is recommended that nursing be discontinued in women who are receiving vinorelbine.

See references

References for pregnancy information

  1. "Product Information. Navelbine (vinorelbine)." Glaxo Wellcome, Research Triangle Pk, NC.

References for breastfeeding information

  1. "Product Information. Navelbine (vinorelbine)." Glaxo Wellcome, Research Triangle Pk, NC.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.